Abstract:Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder characterized by elevated cholesterol levels that frequently leads to premature cardiovascular disease. [ 1 ] The prevalence of FH in the general population varies based on its genetic expression; heterozygous FH affects approximately 1 in 250 to 1 in 313 individuals, whereas homozygous FH is significantly rarer. [ 2 , 3 ] The prevalence is notably higher in patients with ischemic heart disease. A recent meta-analysis revealed a wide variation in FH prevalence among patients with coronary artery disease (CAD), ranging from 0.4% to 25.4%. [ 4 ] In cases of premature CAD, the prevalence of FH is approximately 30 times higher than that in the general population. [ 3 , 5 ]

Prevalence of genetically diagnosed familial hypercholesterolemia in Vietnamese patients with premature acute myocardial infarction